Effectiveness of Dry Needling for Improving Gait in the Patient With M
Analysis of the Effectiveness of Dry Needling for Improving Gait in the Patient With Multiple Sclerosis: a Randomized Single-blind Clinical Trial
We could not find results for this trial
What it found
We found no results in the registry or in papers.
This trial finished 3 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- dry needling + physiotherapy (standard/usual care)
Placebo
- sham dry needling + physiotherapy (standard/usual care)
What it measured
Main measures
Change in Timed 25-Foot Walk (T25FW)
inmediatly before intervention, inmediatly after intervention, a week after the intervention and a month after the intervention
Disability progressionWalking and mobility
Other measures (4)
Change in Multiple Sclerosis Walking Scale (MSWS-12)
inmediatly before intervention, a week after the intervention and a month after the intervention
Walking and mobilityChange in The Time up and go test (TUG)
inmediatly before intervention, inmediatly after intervention, a week after the intervention and a month after the intervention
Walking and mobilityChange in The Multiple Sclerosis International QoL (Musiqol-54)
inmediatly before intervention and a month after the intervention
Quality of life (reported by participants)Change in analog scale of quality of life
inmediatly beforeintervention, a week after intervention and a month after intervention
Quality of life (reported by participants)
Who could take part
MS (type not specified) · 18 to 65
Show the full criteria
Inclusion criteria
1. Having been diagnosed with Multiple Sclerosis in a period of more than two years before the study starts 2. Participate voluntarily and sign the informed consent. 3. Suffering from some type of hypertonia or spasticity in MMII that makes walking difficult, measured with Expanded Disability Status Scale>2 (Pyramidal section >2) 4. Age from 18 to 60 years old. 5. Not having phobia of needles.
Exclusion criteria
1. Not signing the informed consent. 2. Having a phobia of needles. 3. Presenting an outbreak at the start of the study or having presented any outbreak up to two months before the start of the study.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Multiple sclerosis (MS) is a chronic, inflammatory, autoimmune disease characterized by the appearance of lesions, characterized by heterogeneity in its pathological, clinical and radiological presentation. It has a significant socioeconomic impact, affecting interpersonal relationships and causing a significant reduction in quality of life. Patients with MS suffer from a series of symptoms (ocular, spasticity, cerebellar, sensory, fatigue, depression) that may be independent of the course of the disease and their management significantly influences quality of life and also requires multidisciplinary therapeutic measures. Physiotherapy and occupational therapy techniques are essential to reduce spasticity and prevent complications derived from it. Amongst physiotherapy techniques, we can find minimally invasive techniques such as dry needling which uses a fine filiform needle to penetrate the skin and mechanically break the myofascial trigger points, charactewrized by abnomral/pathological electrical activity. There have been previous studies with dry needling in stroke patients which have shown improvements in gait, but its effectiveness in other populations such as multiple sclerosis is still unclear. In addition, dry needling has proven to be a cost-effective treatment for spasticity in patients with chronic and subacute stroke and could be an alternative to other pharmacological treatments, although more studies are necessary to compare both the effectiveness and the cost-effectiveness . Recent studies carried out in patients with multiple sclerosis suggest that dry needling can improve mobility and gait speed. The main objective of the study is to analyze the effect of the application of a single session of dry needling in the lower limbs on the gait of patients with multiple sclerosis. A prospective randomized parallel group clinical trial with blinded outcome assessment will be conducted. Participants will be recruited from the Hospital Universitario de Canarias.
Papers
Loading reviews and guidelines…
History
Started
Jul 2023
Main results due
Nov 2023
Finished
Nov 2023